Skip to main content
Top
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Research article

Whole genome sequencing for the molecular characterization of carbapenem-resistant Klebsiella pneumoniae strains isolated at the Italian ASST Fatebenefratelli Sacco Hospital, 2012–2014

Authors: Sara Giordana Rimoldi, Bernardina Gentile, Cristina Pagani, Annamaria Di Gregorio, Anna Anselmo, Anna Maria Palozzi, Antonella Fortunato, Valentina Pittiglio, Anna Lisa Ridolfo, Maria Rita Gismondo, Giuliano Rizzardini, Florigio Lista

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

The emergence of carbapenem-resistant Klebsiella pneumoniae strains is threatening antimicrobial treatment.

Methods

Sixty-eight carbapenemase-producing K. pneumoniae strains isolated at Luigi Sacco University Hospital-ASST Fatebenefratelli Sacco (Milan, Italy) between 2012 and 2014 were characterised microbiologically and molecularly. They were tested for drug susceptibility and carbapenemase phenotypes, investigated by means of repetitive extra-genic palindromic polymerase chain reaction (REP-PCR), and fully sequenced by means of next-generation sequencing for the in silico analysis of multi-locus sequence typing (MLST), their resistome, virulome and plasmid content, and their core single nucleotide polymorphism (SNP) genotypes.

Results

All of the samples were resistant to carbapenems, other β-lactams and ciprofloxacin; many were resistant to aminoglycosides and tigecycline; and seven were resistant to colistin. Resistome analysis revealed the presence of blaKPC genes and, less frequently blaSHV, blaTEM, blaCTX-M and blaOXA, which are related to resistance to carbapenem and other β-lactams. Other genes conferring resistance to aminoglycoside, fluoroquinolone, phenicol, sulphonamide, tetracycline, trimethoprim and macrolide-lincosamide-streptogramin were also detected. Genes related to AcrAB-TolC efflux pump-dependent and pump-independent tigecycline resistance mechanisms were investigated, but it was not possible to clearly correlate the genomic features with tigecycline resistance because of the presence of a common mutation in susceptible, intermediate and resistant strains. Concerning colistin resistance, the mgrB gene was disrupted by an IS5-like element, and the mobile mcr-1 and mcr-2 genes were not detected in two cases. The virulome profile revealed type-3 fimbriae and iron uptake system genes, which are important during the colonisation stage in the mammalian host environment. The in silico detected plasmid replicons were classified as IncFIB(pQil), IncFIB(K), ColRNAI, IncX1, IncX3, IncFII(K), IncN, IncL/M(pMU407) and IncFIA(HI1). REP-PCR showed five major clusters, and MLST revealed six different sequence types: 512, 258, 307, 1519, 745 and 101. Core SNP genotyping, which led to four clusters, correlated with the MLST data. Isolates of the same sequencing type often had common genetic traits, but the SNP analysis allowed greater strain tracking and discrimination than either the REP-PCR or MLST analysis.

Conclusion

Our findings support the importance of implementing bacterial genomics in clinical medicine in order to complement traditional methods and overcome their limited resolution.
Appendix
Available only for authorised users
Literature
1.
go back to reference Molton JS, Tambyah PA, Ang BS, Ling ML, Fisher DA. The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia. Clin Infect Dis. 2013;56:1310–8.CrossRefPubMed Molton JS, Tambyah PA, Ang BS, Ling ML, Fisher DA. The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia. Clin Infect Dis. 2013;56:1310–8.CrossRefPubMed
2.
go back to reference Morrissey I, Hackel M, Badal R, Bouchillon S, Hawser S, Biedenbach D. A review of ten years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011. Pharmaceuticals. 2013;6:1335–46.CrossRefPubMedPubMedCentral Morrissey I, Hackel M, Badal R, Bouchillon S, Hawser S, Biedenbach D. A review of ten years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011. Pharmaceuticals. 2013;6:1335–46.CrossRefPubMedPubMedCentral
3.
go back to reference van Duijn PJ, Dautzenberg MJ, Oostdijk EA. Recent trends in antibiotic resistance in European ICUs. Curr Opin Crit Care. 2011;17:658–65.CrossRefPubMed van Duijn PJ, Dautzenberg MJ, Oostdijk EA. Recent trends in antibiotic resistance in European ICUs. Curr Opin Crit Care. 2011;17:658–65.CrossRefPubMed
4.
go back to reference Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012;25:682–7.CrossRefPubMedPubMedCentral Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012;25:682–7.CrossRefPubMedPubMedCentral
5.
go back to reference Bush K. Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr Opin Microbiol. 2010;13:558–64.CrossRefPubMed Bush K. Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr Opin Microbiol. 2010;13:558–64.CrossRefPubMed
6.
go back to reference Tijet N, Sheth PM, Lastovetska O, Chung C, Patel SN, Melano RG, et al. Molecular Characterization of Klebsiella pneumoniae Carbapenemase (KPC) - Producing Enterobacteriaceae in Ontario, Canada, 2008-2011. PLoS One. 2014;9:e116421.CrossRefPubMedPubMedCentral Tijet N, Sheth PM, Lastovetska O, Chung C, Patel SN, Melano RG, et al. Molecular Characterization of Klebsiella pneumoniae Carbapenemase (KPC) - Producing Enterobacteriaceae in Ontario, Canada, 2008-2011. PLoS One. 2014;9:e116421.CrossRefPubMedPubMedCentral
7.
go back to reference Mathers AJ, Stoesser N, Chai W, Carroll J, Barry K, Cherunvanky A, et al. Chromosomal integration of the Klebsiella pneumoniae carbapenemase gene, blaKPC, in Klebsiella species is elusive but not rare. Antimicrob Agents Chemother. 2017;61:e01823–16.CrossRefPubMedPubMedCentral Mathers AJ, Stoesser N, Chai W, Carroll J, Barry K, Cherunvanky A, et al. Chromosomal integration of the Klebsiella pneumoniae carbapenemase gene, blaKPC, in Klebsiella species is elusive but not rare. Antimicrob Agents Chemother. 2017;61:e01823–16.CrossRefPubMedPubMedCentral
8.
go back to reference Livermore DM, Warner M, Mushtaq S, Doumith M, Zhang J, Woodford N. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents. 2011;37:415–9.CrossRefPubMed Livermore DM, Warner M, Mushtaq S, Doumith M, Zhang J, Woodford N. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents. 2011;37:415–9.CrossRefPubMed
9.
go back to reference Weterings V, Zhou K, Rossen JW, van Stenis D, Thewessen E, Kluytmans J, Veenemans J. An outbreak of colistin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands (July to December 2013), with inter-institutional spread. Eur J Clin Microbiol Infect Dis. 2015;34:1647–55.CrossRefPubMed Weterings V, Zhou K, Rossen JW, van Stenis D, Thewessen E, Kluytmans J, Veenemans J. An outbreak of colistin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands (July to December 2013), with inter-institutional spread. Eur J Clin Microbiol Infect Dis. 2015;34:1647–55.CrossRefPubMed
10.
go back to reference Monaco M, Giani T, Raffone M, Arena F, Garcia-Fernandez A, Pollini S, Network EuSCAPE-Italy, Grundmann H, Pantosti A, Rossolini GM. Colistin resistance superimposed to endemic carbapenem- resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April. Euro Surveill. 2014;19 (42). Monaco M, Giani T, Raffone M, Arena F, Garcia-Fernandez A, Pollini S, Network EuSCAPE-Italy, Grundmann H, Pantosti A, Rossolini GM. Colistin resistance superimposed to endemic carbapenem- resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April. Euro Surveill. 2014;19 (42).
11.
go back to reference Palmore TN, Henderson DK. Managing transmission of carbapenem-resistant enterobacteriaceae in healthcare settings: a view from the trenches. Clin Infect Dis. 2013;57:1593–9.CrossRefPubMedPubMedCentral Palmore TN, Henderson DK. Managing transmission of carbapenem-resistant enterobacteriaceae in healthcare settings: a view from the trenches. Clin Infect Dis. 2013;57:1593–9.CrossRefPubMedPubMedCentral
12.
go back to reference Giani T, Pini B, Arena F, Conte V, Bracco S, Migliavacca R, the AMCLI-CRE Survey Participants, Pantosti A, Pagani L, Luzzaro F, Rossolini GM. Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011. Euro Surveill. 2013;18 (22). Giani T, Pini B, Arena F, Conte V, Bracco S, Migliavacca R, the AMCLI-CRE Survey Participants, Pantosti A, Pagani L, Luzzaro F, Rossolini GM. Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011. Euro Surveill. 2013;18 (22).
13.
go back to reference Sabat AJ, Budimir A, Nashev D, et al. ESCMID Study Group of Epidemiological Markers (ESGEM). Overview of molecular typing methods for outbreak detection and epidemiological surveillance. Euro Surveill. 2013;18:20380.CrossRefPubMed Sabat AJ, Budimir A, Nashev D, et al. ESCMID Study Group of Epidemiological Markers (ESGEM). Overview of molecular typing methods for outbreak detection and epidemiological surveillance. Euro Surveill. 2013;18:20380.CrossRefPubMed
15.
go back to reference Lee Y, Kim BS, Chun J, Yong JH, Lee YS, Yoo JS, et al. Clonality and Resistome analysis of KPC-producing Klebsiella pneumoniae strain isolated in Korea using whole genome sequencing. Biomed Res Int. 2014;2014:352862.PubMedPubMedCentral Lee Y, Kim BS, Chun J, Yong JH, Lee YS, Yoo JS, et al. Clonality and Resistome analysis of KPC-producing Klebsiella pneumoniae strain isolated in Korea using whole genome sequencing. Biomed Res Int. 2014;2014:352862.PubMedPubMedCentral
16.
go back to reference Zhao F, Bai J, Wu J, Liu J, Zhou M, Xia S, et al. Sequencing and genetic variation of multidrug resistance plasmids in Klebsiella pneumoniae. PLoS One. 2010;5:e10141.CrossRefPubMedPubMedCentral Zhao F, Bai J, Wu J, Liu J, Zhou M, Xia S, et al. Sequencing and genetic variation of multidrug resistance plasmids in Klebsiella pneumoniae. PLoS One. 2010;5:e10141.CrossRefPubMedPubMedCentral
17.
go back to reference Ramirez MS, Traglia GM, Lin DL, Tran T, Tolmasky ME. Plasmid-Mediated Antibiotic Resistance and Virulence in Gram-Negatives: the Klebsiella pneumoniae Paradigm. Microbiol Spectr. 2014;2:1–15.CrossRefPubMedPubMedCentral Ramirez MS, Traglia GM, Lin DL, Tran T, Tolmasky ME. Plasmid-Mediated Antibiotic Resistance and Virulence in Gram-Negatives: the Klebsiella pneumoniae Paradigm. Microbiol Spectr. 2014;2:1–15.CrossRefPubMedPubMedCentral
18.
go back to reference Mathers AJ, Peirano G, Pitout JD. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev. 2015;28:565–91.CrossRefPubMedPubMedCentral Mathers AJ, Peirano G, Pitout JD. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev. 2015;28:565–91.CrossRefPubMedPubMedCentral
22.
go back to reference Simpson JT, Kim Wong K, Shaun D, Jackman SD, Jacqueline E, Schein JE, et al. ABySS: a parallel assembler for short read sequence data. Genome Res. 2009;19:1117–23.CrossRefPubMedPubMedCentral Simpson JT, Kim Wong K, Shaun D, Jackman SD, Jacqueline E, Schein JE, et al. ABySS: a parallel assembler for short read sequence data. Genome Res. 2009;19:1117–23.CrossRefPubMedPubMedCentral
23.
go back to reference Francisco AP, Bugalho M, Ramirez M, Carrico JA. Global Optimal eBURST analysis of Multilocus typing data using a graphic matroid approach. BMC Bioinformatics. 2009;10:152.CrossRefPubMedPubMedCentral Francisco AP, Bugalho M, Ramirez M, Carrico JA. Global Optimal eBURST analysis of Multilocus typing data using a graphic matroid approach. BMC Bioinformatics. 2009;10:152.CrossRefPubMedPubMedCentral
24.
go back to reference Francisco AP, Vaz C, Monteiro PT, Melo-Cristino J, Ramirez M, Carriço JA. PHYLOViZ: phylogenetic inference and data visualization for sequence based typing methods. BMC Bioinformatics. 2012;13:87.CrossRefPubMedPubMedCentral Francisco AP, Vaz C, Monteiro PT, Melo-Cristino J, Ramirez M, Carriço JA. PHYLOViZ: phylogenetic inference and data visualization for sequence based typing methods. BMC Bioinformatics. 2012;13:87.CrossRefPubMedPubMedCentral
25.
go back to reference He F, Fu Y, Chen Q, Ruan Z, Hua X, Zhou H, Yu Y. Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae. PLoS One. 2015;10:e0119064.CrossRefPubMedPubMedCentral He F, Fu Y, Chen Q, Ruan Z, Hua X, Zhou H, Yu Y. Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae. PLoS One. 2015;10:e0119064.CrossRefPubMedPubMedCentral
26.
go back to reference Fang L, Chen Q, Shi K, Li X, Shi Q, He F, et al. Step-wise increase in tigecycline resistance in Klebsiella pneumoniae associated with mutations in ramR, lon and rpsJ. PLoS One. 2016;11:e0165019.CrossRefPubMedPubMedCentral Fang L, Chen Q, Shi K, Li X, Shi Q, He F, et al. Step-wise increase in tigecycline resistance in Klebsiella pneumoniae associated with mutations in ramR, lon and rpsJ. PLoS One. 2016;11:e0165019.CrossRefPubMedPubMedCentral
27.
go back to reference Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16:161–8.CrossRefPubMed Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16:161–8.CrossRefPubMed
28.
go back to reference Xavier BB, Lammens C, Ruhal R, Kumar-Singh S, Butaye P, Goossens H, Malhotra-Kumar S. Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. Euro Surveill. 2016;21(27). Xavier BB, Lammens C, Ruhal R, Kumar-Singh S, Butaye P, Goossens H, Malhotra-Kumar S. Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. Euro Surveill. 2016;21(27).
29.
30.
31.
go back to reference Gardner SN, Hall BG. When whole-genome alignments just won't work: kSNP v2 software for alignment-free SNP discovery and phylogenetics of hundreds of microbial genomes. PLoS One. 2013;8:e81760.CrossRefPubMedPubMedCentral Gardner SN, Hall BG. When whole-genome alignments just won't work: kSNP v2 software for alignment-free SNP discovery and phylogenetics of hundreds of microbial genomes. PLoS One. 2013;8:e81760.CrossRefPubMedPubMedCentral
32.
go back to reference Huson DH and Scornavacca C. Dendroscope 3: an interactive tool for rooted phylogenetic trees and networks, Syst. Biol. 2012; 61: 1061–7. (Software freely available at http://dendroscope.org). Huson DH and Scornavacca C. Dendroscope 3: an interactive tool for rooted phylogenetic trees and networks, Syst. Biol. 2012; 61: 1061–7. (Software freely available at http://​dendroscope.​org).
33.
go back to reference Lee C-R, Lee JH, Park KS, Kim YB, Jeong BC, Lee SH. Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods. Front Microbiol. 2016;7:895.PubMedPubMedCentral Lee C-R, Lee JH, Park KS, Kim YB, Jeong BC, Lee SH. Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods. Front Microbiol. 2016;7:895.PubMedPubMedCentral
34.
go back to reference Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9:228–36.CrossRefPubMed Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9:228–36.CrossRefPubMed
35.
go back to reference Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol. 2008;29:1099–106.CrossRefPubMed Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol. 2008;29:1099–106.CrossRefPubMed
36.
go back to reference Mammina C, Palma DM, Bonura C, Anna Plano MR, Monastero R, Sodano C, et al. Outbreak of infection with Klebsiella pneumoniae sequence type 258 producing Klebsiella pneumoniae Carbapenemase 3 in an intensive care unit in Italy. J Clin Microbiol. 2010;48:1506–7.CrossRefPubMedPubMedCentral Mammina C, Palma DM, Bonura C, Anna Plano MR, Monastero R, Sodano C, et al. Outbreak of infection with Klebsiella pneumoniae sequence type 258 producing Klebsiella pneumoniae Carbapenemase 3 in an intensive care unit in Italy. J Clin Microbiol. 2010;48:1506–7.CrossRefPubMedPubMedCentral
37.
go back to reference Giani T, Arena F, Vaggelli G, Conte V, Chiarelli A, Henrici De Angelis L, et al. Large nosocomial outbreak of colistin-resistant, carbapenemase-producing Klebsiella pneumoniae traced to clonal expansion of an mgrB deletion mutant. J Clin Microbiol. 2015;53:3341–4.CrossRefPubMedPubMedCentral Giani T, Arena F, Vaggelli G, Conte V, Chiarelli A, Henrici De Angelis L, et al. Large nosocomial outbreak of colistin-resistant, carbapenemase-producing Klebsiella pneumoniae traced to clonal expansion of an mgrB deletion mutant. J Clin Microbiol. 2015;53:3341–4.CrossRefPubMedPubMedCentral
38.
go back to reference Ridolfo AL, Rimoldi SG, Pagani C, Marino AF, Piol A, Rimoldi M, et al. Diffusion and transmission of carbapenems-resistant Klebsiella pneumoniae in the medical and surgical wards of a university hospital in Milan, Italy. J Infect Public Health. 2016;9:24–33.CrossRefPubMed Ridolfo AL, Rimoldi SG, Pagani C, Marino AF, Piol A, Rimoldi M, et al. Diffusion and transmission of carbapenems-resistant Klebsiella pneumoniae in the medical and surgical wards of a university hospital in Milan, Italy. J Infect Public Health. 2016;9:24–33.CrossRefPubMed
39.
go back to reference Snitkin ES, Zelazny AM, Thomas PJ, Stock F; NISC Comparative Sequencing Program Group, Henderson DK, Palmore TN, Segre JA. Tracking a Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae with Whole-Genome Sequencing. Sci Transl Med. 2012;4:148ra116. Snitkin ES, Zelazny AM, Thomas PJ, Stock F; NISC Comparative Sequencing Program Group, Henderson DK, Palmore TN, Segre JA. Tracking a Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae with Whole-Genome Sequencing. Sci Transl Med. 2012;4:148ra116.
40.
go back to reference Onori R, Gaiarsa S, Comandatore F, Pongolini S, Brisse S, Colombo A, et al. Tracking nosocomial Klebsiella pneumoniae infections and outbreaks by whole genome analysis: small-scale Italian scenario within a single hospital. J Clin Microbiol. 2015;53:2861–8.CrossRefPubMedPubMedCentral Onori R, Gaiarsa S, Comandatore F, Pongolini S, Brisse S, Colombo A, et al. Tracking nosocomial Klebsiella pneumoniae infections and outbreaks by whole genome analysis: small-scale Italian scenario within a single hospital. J Clin Microbiol. 2015;53:2861–8.CrossRefPubMedPubMedCentral
41.
42.
go back to reference Ong C-LY, Beatson SA, Totsika M, Forestier C, McEwan AG, Schembri MA. Molecular analysis of type 3 fimbrial genes from Escherichia coli, Klebsiella and Citrobacter species. BMC Microbiol. 2010;10:183.CrossRefPubMedPubMedCentral Ong C-LY, Beatson SA, Totsika M, Forestier C, McEwan AG, Schembri MA. Molecular analysis of type 3 fimbrial genes from Escherichia coli, Klebsiella and Citrobacter species. BMC Microbiol. 2010;10:183.CrossRefPubMedPubMedCentral
43.
go back to reference Bialek-Davenet S, Criscuolo A, Ailloud F, Passet V, Jones L, Delannoy-Vieillard AS, et al. Genomic definition of hypervirulent and multidrug-resistant Klebsiella pneumoniae clonal groups. Emerg Infect Dis. 2014;20:1812–20.CrossRefPubMedPubMedCentral Bialek-Davenet S, Criscuolo A, Ailloud F, Passet V, Jones L, Delannoy-Vieillard AS, et al. Genomic definition of hypervirulent and multidrug-resistant Klebsiella pneumoniae clonal groups. Emerg Infect Dis. 2014;20:1812–20.CrossRefPubMedPubMedCentral
44.
go back to reference Schaible UE, Kaufmann SHE. Iron and microbial infection. Nat Rev. 2004;2:946–53. Schaible UE, Kaufmann SHE. Iron and microbial infection. Nat Rev. 2004;2:946–53.
45.
go back to reference De Jesus MB, Ehlers MM, Dos Santos RF, Kock MM. Understanding β-lactamase producing Klebsiella pneumoniae. InTechOpen. 2015; doi:10.5772/61852. De Jesus MB, Ehlers MM, Dos Santos RF, Kock MM. Understanding β-lactamase producing Klebsiella pneumoniae. InTechOpen. 2015; doi:10.​5772/​61852.
46.
go back to reference Carattoli A, Zankari E, Garcia-Fernandez A, Volby Larsen M, Lund O, Villa L, et al. PlasmidFinder and pMLST: in silico detection and typing of plasmids. Antimicrob Agents Chemother. 2014;58:3895–903.CrossRefPubMedPubMedCentral Carattoli A, Zankari E, Garcia-Fernandez A, Volby Larsen M, Lund O, Villa L, et al. PlasmidFinder and pMLST: in silico detection and typing of plasmids. Antimicrob Agents Chemother. 2014;58:3895–903.CrossRefPubMedPubMedCentral
47.
go back to reference Ramos PI, Picão RC, Almeida LG, Lima NC, Girardello R, Vivan AC, et al. Comparative analysis of the complete genome of KPC-2-producing Klebsiella pneumoniae Kp13 reveals remarkable genome plasticity and a wide repertoire of virulence and resistance mechanisms. BMC Genomics. 2014;15:54.CrossRefPubMedPubMedCentral Ramos PI, Picão RC, Almeida LG, Lima NC, Girardello R, Vivan AC, et al. Comparative analysis of the complete genome of KPC-2-producing Klebsiella pneumoniae Kp13 reveals remarkable genome plasticity and a wide repertoire of virulence and resistance mechanisms. BMC Genomics. 2014;15:54.CrossRefPubMedPubMedCentral
48.
go back to reference Conte V, Monaco M, Giani T, D'Ancona F, Moro ML, Arena F, et al. AR-ISS Study Group on Carbapenemase-Producing K. pneumoniae. Molecular epidemiology of KPC-producing Klebsiella pneumoniae from invasive infections in Italy: increasing diversity with predominance of the ST512 clade II sublineage. J Antimicrob Chemother. 2016;71:3386–91.CrossRefPubMed Conte V, Monaco M, Giani T, D'Ancona F, Moro ML, Arena F, et al. AR-ISS Study Group on Carbapenemase-Producing K. pneumoniae. Molecular epidemiology of KPC-producing Klebsiella pneumoniae from invasive infections in Italy: increasing diversity with predominance of the ST512 clade II sublineage. J Antimicrob Chemother. 2016;71:3386–91.CrossRefPubMed
Metadata
Title
Whole genome sequencing for the molecular characterization of carbapenem-resistant Klebsiella pneumoniae strains isolated at the Italian ASST Fatebenefratelli Sacco Hospital, 2012–2014
Authors
Sara Giordana Rimoldi
Bernardina Gentile
Cristina Pagani
Annamaria Di Gregorio
Anna Anselmo
Anna Maria Palozzi
Antonella Fortunato
Valentina Pittiglio
Anna Lisa Ridolfo
Maria Rita Gismondo
Giuliano Rizzardini
Florigio Lista
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2760-7

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.